DREAMing: A simple and ultrasensitive method for assessing intratumor epigenetic heterogeneity directly from liquid biopsies

Nucleic Acids Research

Volumn 43, Issue 22, 2015, Pages

  Pisanic, Thomas R ^a   Athamanolap, Pornpat ^b   Poh, Weijie ^c   Chen, Chen ^c,d   Hulbert, Alicia ^c   Brock, Malcolm V ^c   Herman, James G ^c   Wang, Tza Huei ^a,b,c  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; PRIMER DNA;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CPG ISLAND; DILUTION; DISCRIMINATION OF RARE EPIALLELE BY MELT; DNA METHYLATION; EPIGENETICS; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC PROCEDURES; GENETIC VARIABILITY; HUMAN; MEASUREMENT PRECISION; MIXED MYELODYSPLASTIC MYELOPROLIFERATIVE DISEASE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROMOTER REGION; SENSITIVITY ANALYSIS; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE; ALLELE; BIOPSY; BLOOD; CHEMISTRY; DNA DENATURATION; DNA SEQUENCE; GENETIC EPIGENESIS; GENETIC VARIATION; GENETICS; LUNG TUMOR; MALE; MYELODYSPLASTIC SYNDROME; NEOPLASM; PATHOLOGY; PROCEDURES; STATISTICAL ANALYSIS;

ALLELES; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CPG ISLANDS; DATA INTERPRETATION, STATISTICAL; DNA METHYLATION; DNA PRIMERS; DNA, NEOPLASM; EPIGENESIS, GENETIC; EPIGENOMICS; GENETIC VARIATION; HUMANS; LUNG NEOPLASMS; MALE; MYELODYSPLASTIC SYNDROMES; NEOPLASMS; NUCLEIC ACID DENATURATION; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 84964556069     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv795     Document Type: Article

References (66)

1. Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A. and Kinzler, K. W. (2013) Cancer Genome Landscapes. Science, 339, 1546-1558.
2. Hanahan, D. and Weinberg, R. A. Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674.
3. Herman, J. G. and Baylin, S. B. (2003) Gene Silencing in Cancer in Association with Promoter Hypermethylation. N. Engl. J. Med., 349, 2042-2054.
4. Nephew, K. P. and Huang, T. H.-M. (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Letters, 190, 125-133.
5. Heyn, H. and Esteller, M. (2012) DNA methylation profiling in the clinic: applications and challenges. Nat. Rev. Genet., 13, 679-692.
6. Landan, G., Cohen, N. M., Mukamel, Z., Bar, A., Molchadsky, A., Brosh, R., Horn-Saban, S., Zalcenstein, D. A., Goldfinger, N., Zundelevich, A. et al. (2012) Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat. Genet., 44, 1207-1214.
7. Feinberg, A. P., Ohlsson, R. and Henikoff, S. (2006) The epigenetic progenitor origin of human cancer. Nat. Rev. Genet., 7, 21-33.
8. Easwaran, H., Tsai, H.-C. and Baylin, S. B. Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance. Mol. Cell, 54, 716-727.
9. Brown, R., Curry, E., Magnani, L., Wilhelm-Benartzi, C. S. and Borley, J. (2014) Poised epigenetic states and acquired drug resistance in cancer. Nat. Rev. Cancer., 14, 747-753.
10. Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A. et al. (2010) A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations. Cell, 141, 69-80.
11. Meacham, C. E. and Morrison, S. J. (2013) Tumour heterogeneity and cancer cell plasticity. Nature, 501, 328-337.
12. Bedard, P. L., Hansen, A. R., Ratain, M. J. and Siu, L. L. (2013) Tumour heterogeneity in the clinic. Nature, 501, 355-364.
13. Turner, N. C. and Reis-Filho, J. S. (2012) Genetic heterogeneity and cancer drug resistance. Lancet Oncol., 13, e178-e185.
14. Landau, D. A., Clement, K., Ziller, M. J., Boyle, P., Fan, J., Gu, H., Stevenson, K., Sougnez, C., Wang, L., Li, S. et al. Locally Disordered Methylation Forms the Basis of Intratumor Methylome Variation in Chronic Lymphocytic Leukemia. Cancer Cell, 26, 813-825.
15. Oakes, C. C., Claus, R., Gu, L., Assenov, Y., Hüllein, J., Zucknick, M., Bieg, M., Brocks, D., Bogatyrova, O., Schmidt, C. R. et al. (2014) Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia. Cancer Discov., 4, 348-361.
16. Schwarzenbach, H., Hoon, D. S. B. and Pantel, K. (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer, 11, 426-437.
17. Shipony, Z., Mukamel, Z., Cohen, N. M., Landan, G., Chomsky, E., Zeliger, S. R., Fried, Y. C., Ainbinder, E., Friedman, N. and Tanay, A. (2014) Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature, 513, 115-119.
18. Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S. and Getz, G. (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotech., 31, 213-219.
19. Diaz, L. A. and Bardelli, A. (2014) Liquid Biopsies: Genotyping Circulating Tumor DNA. J. Clin. Oncol., 32, 579-586.
20. Ilie, M., Hofman, V., Long, E., Bordone, O., Selva, E., Washetine, K., Marquette, C. H. and Hofman, P. (2014) Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine? Ann. Transl. Med., 2, 107.
21. Curradi, M., Izzo, A., Badaracco, G. and Landsberger, N. (2002) Molecular Mechanisms of Gene Silencing Mediated by DNA Methylation. Mol. Cell. Biol., 22, 3157-3173.
22. Herman, J. G., Graff, J. R., Mÿohänen, S., Nelkin, B. D. and Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Nat. Acad. Sci., 93, 9821-9826.
23. Lo, Y. M. D., Wong, I. H. N., Zhang, J., Tein, M. S. C., Ng, M. H. L. and Hjelm, N. M. (1999) Quantitative Analysis of Aberrant p16 Methylation Using Real-Time QuantitativeMethylation-specific Polymerase Chain Reaction. Cancer Res., 59, 3899-3903.
24. Eads, C. A., Danenberg, K. D., Kawakami, K., Saltz, L. B., Blake, C., Shibata, D., Danenberg, P. V. and Laird, P. W. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res., 28, e32.
25. Bibikova, M., Lin, Z., Zhou, L., Chudin, E., Garcia, E. W., Wu, B., Doucet, D., Thomas, N. J., Wang, Y., Vollmer, E. et al. (2006) High-throughput DNA methylation profiling using universal bead arrays. Genome Res., 16, 383-393.
26. Taylor, K. H., Kramer, R. S., Davis, J. W., Guo, J., Duff, D. J., Xu, D., Caldwell, C. W. and Shi, H. (2007) Ultradeep Bisulfite Sequencing Analysis of DNA Methylation Patterns in Multiple Gene Promoters by 454 Sequencing. Cancer Res., 67, 8511-8518.
27. Meissner, A., Gnirke, A., Bell, G. W., Ramsahoye, B., Lander, E. S. and Jaenisch, R. (2005) Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res., 33, 5868-5877.
28. Mikeska, T., Candiloro, I. L. M. and Dobrovic, A. (2010) The implications of heterogeneous DNA methylation for the accurate quantification of methylation. Epigenomics, 2, 561-573.
29. Laird, P. W. (2010) Principles and challenges of genome-wide DNA methylation analysis. Nat. Rev. Genet., 11, 191-203.
30. Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E. et al. (2014) An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med., 20, 552-558.
31. Varley, K. E., Mutch, D. G., Edmonston, T. B., Goodfellow, P. J. and Mitra, R. D. (2009) Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing. Nucleic Acids Res., 37, 4603-4612.
32. Wang, Q., Jia, P., Cheng, F. and Zhao, Z. (2015) Heterogeneous DNA methylation contributes to tumorigenesis through inducing the loss of coexpression connectivity in colorectal cancer. Genes Chromosomes Cancer, 54, 110-121.
33. Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B. and Herman, J. G. (2000) Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem., 275, 2727-2732.
34. Moelans, C. B., De Groot, J. S., Pan, X., Van Der Wall, E. and Van Diest, P. J. (2014) Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA. Mod. Pathol., 27, 869-874.
35. Nabilsi, N. H., Deleyrolle, L. P., Darst, R. P., Riva, A., Reynolds, B. A. and Kladde, M. P. (2014) Multiplex mapping of chromatin accessibility and DNA methylation within targeted single molecules identifies epigenetic heterogeneity in neural stem cells and glioblastoma. Genome Res., 24, 329-339.
36. Wojdacz, T. K., Dobrovic, A. and Hansen, L. L. (2008) Methylation-sensitive high-resolution melting. Nat. Protoc., 3, 1903-1908.
37. Tusńady, G. E., Simon, I., Váradi, A. and Aŕanyi, T. (2005) BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes. Nucleic Acids Res., 33, e9.
38. Dwight, Z., Palais, R. and Wittwer, C. T. (2011) uMELT: prediction of high-resolution melting curves and dynamic melting profiles of PCR products in a rich web application. Bioinformatics, 27, 1019-1020.
39. Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W. et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416, 552-556.
40. Keeley, B., Stark, A., Pisanic II, T. R., Kwak, R., Zhang, Y., Wrangle, J., Baylin, S., Herman, J., Ahuja, N., Brock, M. V. et al. (2013) Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. Clin. Chim. Acta, 425, 169-175.
41. Genereux, D. P., Johnson, W. C., Burden, A. F., Sẗoger, R. and Laird, C. D. (2008) Errors in the bisulfite conversion of DNA: modulating inappropriate- and failed-conversion frequencies. Nucleic Acids Res., 36, e150.
42. Korbie, D. J. and Mattick, J. S. (2008) Touchdown PCR for increased specificity and sensitivity in PCR amplification. Nat. Protoc., 3, 1452-1456.
43. Esteller, M., Tortola, S., Toyota, M., Capella, G., Peinado, M. A., Baylin, S. B. and Herman, J. G. (2000) Hypermethylation-associated Inactivation of p14ARF Is Independent of p16INK4a Methylation and p53 Mutational Status. Cancer Res., 60, 129-133.
44. Blake, R. D. and Delcourt, S. G. (1998) Thermal stability of DNA. Nucleic Acids Res., 26, 3323-3332.
45. Bailey, V. J., Zhang, Y., Keeley, B. P., Yin, C., Pelosky, K. L., Brock, M., Baylin, S. B., Herman, J. G. and Wang, T.-H. (2010) Single-Tube Analysis of DNA Methylation with Silica Superparamagnetic Beads. Clin. Chem., 56, 1022-1025
46. Mao, F., Leung, W.-Y. and Xin, X. (2007) Characterization of EvaGreen and the implication of its physicochemical properties for qPCR applications. BMC Biotechnol., 7, 76.
47. Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K. H. et al. (1998) The alternative product from the human CDKN2A locus, p14 (ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J., 17, 5001-5014.
48. Hsu, H.-S., Wang, Y.-C., Tseng, R.-C., Chang, J.-W., Chen, J.-T., Shih, C.-M., Chen, C.-Y. and Wang, Y.-C. (2004) CpG Island Methylation Is Responsible for p14ARF Inactivation and Inversely Correlates with p53 Overexpression in Resected Non-Small Cell Lung Cancer. Clin. Cancer Res., 10, 4734-4741.
49. Fischer, J. R., Ohnmacht, U., Rieger, N., Zemaitis, M., Stoffregen, C., Manegold, C. and Lahm, H. (2007) Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine. Lung Cancer, 56, 115-123.
50. Saito, K., Takigawa, N., Ohtani, N., Iioka, H., Tomita, Y., Ueda, R., Fukuoka, J., Kuwahara, K., Ichihara, E., Kiura, K. et al. (2013) Antitumor Impact of p14ARF on Gefitinib-Resistant Non-Small Cell Lung Cancers. Mol. Cancer Ther., 12, 1616-1628.
51. Veeck, J., Ropero, S., Setien, F., Gonzalez-Suarez, E., Osorio, A., Benitez, J., Herman, J. G. and Esteller, M. (2010) BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly (Adenosine Diphosphate) - Ribose Polymerase Inhibitors. J. Clin. Oncol., 28, e563-e564.
52. Poh, W., Moliterno, A. R., Pratz, K. W., Gojo, I., McDevitt, M. A. and Herman, J. G. (2014) Epigenetic Silencing of BRCA1 Is Linked to Homologous Recombination Repair Defects and Elevated Mir-155 Expression in Myeloid Neoplasms. Blood, 124, 3525-3525.
53. Holmes, E. E., Jung, M., Meller, S., Leisse, A., Sailer, V., Zech, J., Mengdehl, M., Garbe, L.-A., Uhl, B., Kristiansen, G. et al. (2014) Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine. PLoS ONE, 9, e93933.
54. Warnecke, P. M., Stirzaker, C., Song, J., Grunau, C., Melki, J. R. and Clark, S. J. (2002) Identification and resolution of artifacts in bisulfite sequencing. Methods, 27, 101-107.
55. McGranahan, N. and Swanton, C. (2015) Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution. Cancer Cell, 27, 15-26.
56. Shackleton, M., Quintana, E., Fearon, E. R. and Morrison, S. J. (2009) Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution. Cell, 138, 822-829.
57. Reya, T., Morrison, S. J., Clarke, M. F. and Weissman, I. L. (2001) Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111.
58. Magee, J. A., Piskounova, E. and Morrison, S. J. (2012) Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty. Cancer Cell, 21, 283-296.
59. Nowell, P. C. (1976) The Clonal Evolution of Tumor Cell Populations. Science, 194, 23-28.
60. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. and Clarke, M. F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Nat. Acad. Sci., 100, 3983-3988.
61. Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C. and De Maria, R. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature, 445, 111-115.
62. Candiloro, I., Mikeska, T., Hokland, P. and Dobrovic, A. (2008) Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene. Epigenetics & Chromatin, 1, 7.
63. Newcombe, R. G. (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stati. Med., 17, 857-872.
64. Lorincz, M. C., Schübeler, D., Goeke, S. C., Walters, M., Groudine, M. and Martin, D. I. K. (2000) Dynamic Analysis of Proviral Induction and De Novo Methylation: Implications for a Histone Deacetylase-Independent, Methylation Density-Dependent Mechanism of Transcriptional Repression. Mol. Cell. Biol., 20, 842-850.
65. Cameron, E. E., Baylin, S. B. and Herman, J. G. (1999) p15INK4B CpG Island Methylation in Primary Acute Leukemia Is Heterogeneous and Suggests Density as a Critical Factor for Transcriptional Silencing. Blood, 94, 2445-2451.
66. Lo, Y. M. D. and Chiu, R. W. K. (2007) Prenatal diagnosis: progress through plasma nucleic acids., Nat. Rev. Genet., 8, 71-77.